Article
Targeted apoptosis of myofibroblasts by elesclomol inhibits hypertrophic scar formation
1 Apr 2020
Abstract excerpt
BACKGROUND: Hypertrophic scar (HS) is characterized by the increased proliferation and decreased apoptosis of myofibroblasts. Myofibroblasts, the main effector cells for dermal fibrosis, develop from normal fibroblasts. Thus, the stimulation of myofibroblast apoptosis is a possible treatment for HS. We aimed to explore that whether over-activated myofibroblasts can be targeted for apoptosis by anticancer drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
